SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (20218)3/31/1999 11:27:00 PM
From: VLAD  Respond to of 23519
 
More good news from the 10K:

"In addition, the Company initiated a study to examine the efficacy of MUSE in patients who were contraindicated from using sildenafil, had a significant side effect from sildenafil, or who had failed to have an adequate response to sildenafil therapy. The results of this study will be presented at the 1999 meeting of the American Urological Association in Dallas, May 1-6, 1999."